Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx

Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx

Objective<p>Silicosis is characterized by silicon nodules and diffuse pulmonary fibrosis. To date, no effective therapy has been developed for the treatment of silicosis. This study aimed to investigate the effects of Galunisertib, a TGF-β receptor I kinase inhibitor, on the autophagy-lysosome...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Rou Li (11575418) (author)
Andere auteurs: Huimin Kang (435951) (author), Aoxiang Hu (22679153) (author), Guo Chen (182090) (author), Tinghua Yan (18786622) (author), Ting Liu (45625) (author), Shi Chen (120917) (author)
Gepubliceerd in: 2025
Onderwerpen:
Pharmacology
Galunisertib
silicosis
TGF-β
autophagy
fibrosis
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Gelijkaardige items